Piper Sandler Achieves Record Q1 Revenues with Strong DCM Advisory Growth
Piper Sandler posted record Q1 revenues driven by strong debt capital markets advisory, busy derivative desk hedging activity and growing private capital advisory contributions. Advisory fees face sequential moderation as announced bank M&A slows and healthcare and medtech transaction volume proves hard to replicate.
1. Record Q1 Revenues and Diversification
Piper Sandler achieved record first-quarter revenue, led by a surge in debt capital markets advisory fees, heightened derivative hedging transactions with bank clients and continued growth in private capital advisory. Restructuring services also contributed, underscoring a diversified revenue base.
2. Advisory Backlog and Sector Trends
Advisory fees are expected to decline sequentially following a choppy macro backdrop, as announced bank M&A volume has slowed and larger sponsor-led transactions remain cautious. Healthcare and medtech segments delivered exceptional Q1 performance but are unlikely to match this pace in the near term.
3. Equity Capital Markets and Healthcare Focus
Equity capital markets saw outsized market share gains in healthcare and industrials, particularly in biotech, though this performance may not be sustainable into Q2. Technology M&A moderated as valuation declines and AI-related uncertainties dampened larger software deals.